These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Acuity recovery and cone pigment regeneration after a bleach in patients with retinitis pigmentosa and rhodopsin mutations. Sandberg MA; Pawlyk BS; Berson EL Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2457-61. PubMed ID: 10476820 [TBL] [Abstract][Full Text] [Related]
28. Photopic electroretinogram implicit time in retinitis pigmentosa. Iijima H; Yamaguchi S; Hosaka O Jpn J Ophthalmol; 1993; 37(2):130-5. PubMed ID: 8230836 [TBL] [Abstract][Full Text] [Related]
29. S-cone function in patients with retinitis pigmentosa. Gouras P; MacKay CJ Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):781-3. PubMed ID: 8125738 [No Abstract] [Full Text] [Related]
30. Histopathologic study of an unusual form of retinitis pigmentosa. Szamier RB; Berson EL Invest Ophthalmol Vis Sci; 1982 May; 22(5):559-70. PubMed ID: 7076403 [TBL] [Abstract][Full Text] [Related]
32. Approaches to human retinitis pigmentosa through studies of vitamin A metabolism in the RCS (dystrophic) rat. Berman ER; Merin S; Segal N; Photiou S Birth Defects Orig Artic Ser; 1982; 18(6):135-48. PubMed ID: 7171749 [No Abstract] [Full Text] [Related]
33. Low-frequency damped electroretinographic wavelets in young asymptomatic patients with dominant retinitis pigmentosa: a new electroretinographic finding. Lam BL; Liu M; Hamasaki DI Ophthalmology; 1999 Jun; 106(6):1109-13. PubMed ID: 10366078 [TBL] [Abstract][Full Text] [Related]
34. Disease course of patients with pericentral retinitis pigmentosa. Sandberg MA; Gaudio AR; Berson EL Am J Ophthalmol; 2005 Jul; 140(1):100-6. PubMed ID: 15953579 [TBL] [Abstract][Full Text] [Related]
35. [Retinitis pigmentosa and hyperbaric oxygen therapy]. Vérin P; Comte P; Poisot D Bull Soc Ophtalmol Fr; 1986; 86(8-9):1071-2, 1074. PubMed ID: 3568248 [No Abstract] [Full Text] [Related]
36. [Treatment with hyperbaric oxygen. Illustrated by the treatment of a patient with retinitis pigmentosa]. Skogstad M; Bast-Pettersen R; Tynes T; Bjørnsen D; Aaserud O Tidsskr Nor Laegeforen; 1994 Sep; 114(21):2480-3. PubMed ID: 7940448 [TBL] [Abstract][Full Text] [Related]
37. Review and update: current treatment trends for patients with retinitis pigmentosa. Shintani K; Shechtman DL; Gurwood AS Optometry; 2009 Jul; 80(7):384-401. PubMed ID: 19545852 [TBL] [Abstract][Full Text] [Related]
38. Photoreceptor apoptosis in animal models. Implications for retinitis pigmentosa research. Wong F Arch Ophthalmol; 1995 Oct; 113(10):1245-7. PubMed ID: 7575254 [No Abstract] [Full Text] [Related]
39. [Pathologic physiology of tapetoretinal degeneration. 4. On the mechanism of the disturbance of light sense in retinitis pigmentosa]. Komi T; Uchida S Nippon Ganka Gakkai Zasshi; 1964 Mar; 68(4):181-4. PubMed ID: 5892375 [No Abstract] [Full Text] [Related]
40. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Birch DG; Anderson JL; Fish GE Ophthalmology; 1999 Feb; 106(2):258-68. PubMed ID: 9951474 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]